Voyager Therapeutics Inc - ESG Rating & Company Profile powered by AI
If you are employed by Voyager Therapeutics Inc and you wish to licence your Sustainability aseessment, please contact us. The report of Voyager Therapeutics Inc leverages data points from across the web and also from available disclosures by Voyager Therapeutics Inc. Check the bottom of the page for potential risks for Voyager Therapeutics Inc based on industry, location and marketcap.
Voyager Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 6.0, social score of 4.0 and governance score of 4.6.
4.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Novartis AG | 9.2 | High |
| 2 | Daiichi Sankyo Co Ltd | 8.9 | High |
| 1047 | SQZ Biotechnologies Co | 5.0 | High |
| 1047 | Zenabis Global Inc | 5.0 | High |
| 1082 | Voyager Therapeutics Inc | 4.9 | High |
| 1082 | AngioLab Inc | 4.9 | High |
| 1082 | Annexon Inc | 4.9 | High |
| ... | ... | ... | |
| 2749 | Xynomic Pharmaceuticals Holdings Inc | 0.0 | Low |
| 2749 | Zyden Gentec Ltd | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Voyager Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Voyager Therapeutics Inc report the average age of the workforce?
Sign up for free to unlockDoes Voyager Therapeutics Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Voyager Therapeutics Inc offer flexible work?
Sign up for free to unlockDoes Voyager Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Voyager Therapeutics Inc conduct supply chain audits?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Voyager Therapeutics Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose water use targets?
Sign up for free to unlockDoes Voyager Therapeutics Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Voyager Therapeutics Inc have a product recall in the last two years?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Voyager Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Voyager Therapeutics Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose parental leave metrics?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Voyager Therapeutics Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Voyager Therapeutics Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Voyager Therapeutics Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose its waste policy?
Sign up for free to unlockDoes Voyager Therapeutics Inc report according to TCFD requirements?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose energy use targets?
Sign up for free to unlockDoes Voyager Therapeutics Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Voyager Therapeutics Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Voyager Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyotrophic lateral sclerosis; VY-HTT01 for Huntington's disease; VY-FXN01 for Friedreich's ataxia; and Tau program for the treatment of tauopathies, including Alzheimer's disease, progressive supranuclear palsy, and frontotemporal dementia, as well as for spinal muscular atrophy. The company has collaboration and license agreements with Neurocrine Biosciences, Inc., Pfizer Inc., and Novartis Pharma, A.G. for the research, development, and commercialization of adeno-associated virus gene therapy products. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Cambridge, Massachusetts.